Results 31 to 40 of about 1,023,792 (288)
ERA OF CONJUGATE VACCINES: INTERNATIONAL EXPERIENCE OF SUCCESSFUL APPLICATION
Педиатрическая фармакология, 2008 The article highlights comparative characteristics of the polysaccharide and conjugate vaccines against pneumococcal infection, meningococcosis and haemophilus influenza. The author stresses the advantage of the conjugate vaccines.
M.V. Fedoseenko +2 more
doaj +2 more sources
Expert Review of Vaccines, 2017 Introduction: Protein D-containing vaccines may decrease acute otitis media (AOM) burden and nasopharyngeal carriage of non-typeable Haemophilus influenzae (NTHi).
Christopher Clarke +4 more
semanticscholar +1 more source
Production of glycoprotein vaccines in
Microbial Cell Factories, 2010 Background Conjugate vaccines in which polysaccharide antigens are covalently linked to carrier proteins belong to the most effective and safest vaccines against bacterial pathogens.
Ihssen Julian +5 more
doaj +1 more source
Biosynthesis of Conjugate Vaccines Using an O-Linked Glycosylation System
mBio, 2016 Conjugate vaccines are known to be one of the most effective and safest types of vaccines against bacterial pathogens. Previously, vaccine biosynthesis has been performed by using N-linked glycosylation systems.
Chao Pan +12 more
semanticscholar +1 more source
Human Vaccines & Immunotherapeutics, 2022 Vaccination offers the best way to prevent invasive meningococcal disease (IMD). As demonstrated in countries with national immunization programs (NIPs) against IMD, meningococcal conjugate vaccines have contributed to significant declines in incidence ...
Gary S. Marshall +3 more
doaj +1 more source
bioRxiv, 2021 Controlling the global COVID-19 pandemic depends, among other measures, on developing preventive vaccines at an unprecedented pace. Vaccines approved for use and those in development intend to use neutralizing antibodies to block viral sites binding to ...
Yury Valdés-Balbín +43 more
semanticscholar +1 more source
Expert Review of Vaccines, 2003 Conjugate vaccines in which the capsular polysaccharide of Haemophilus influenzae type b, common serotypes of Streptococcus pneumoniae and group C Neisseria meningitidis are covalently bound to a protein antigen to convert a T-cell-independent immune response into a T-cell-dependent response have proved highly effective in the prevention of invasive ...
openaire +2 more sources
Evolution of conjugate vaccines
Expert Review of Vaccines, 2002 Conjugate vaccines--bacterial polysaccharides conjugated to proteins to improve their immunizing properties--have been a success story since their introduction less than 20 years ago. The Haemophilus influenzae type b conjugate vaccine has nearly eliminated invasive Haemophilus influenzae type b disease in large parts of the world.
P. Helena Mäkelä, Helena Käyhty
openaire +3 more sources
Factors contributing to the immunogenicity of meningococcal conjugate vaccines
Human Vaccines & Immunotherapeutics, 2016 Various glycoprotein conjugate vaccines have been developed for the prevention of invasive meningococcal disease, having significant advantages over pure polysaccharide vaccines.
M. Bröker, F. Berti, P. Costantino
semanticscholar +1 more source
Human Vaccines & Immunotherapeutics, 2020 Simultaneous administration of different vaccines is a strategy to increase the possibility to receive vaccines at appropriate age, safely and effectively, reducing the number of sessions and allowing a more acceptable integration of new vaccines into ...
Paolo Bonanni +6 more
doaj +1 more source